Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
Brief description of study
To investigate the safety and efficacy of Tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Diabetic Gastroparesis
-
Age: Between 18 Years - 70 Years
-
Gender: All
Male or Female, Age 18-70, Diagnosed with gastroparesis
Updated on
09 Mar 2024.
Study ID: 834091
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting